Literature DB >> 6757872

Fluid and electrolyte disturbances associated with cancer and its treatment.

S G Cunningham.   

Abstract

Individuals with cancer are subject to fluid and electrolyte imbalances because of the original disease process, therapy, and complications resulting from both the disease process and from therapy. These imbalances are life threatening either when they become extreme or when they occur very rapidly. Although almost any fluid and electrolyte disorder or combination of disorders can occur in people with cancer, this article will focus on the following more common, potentially critical imbalances: water excess, decreased vascular volume, hypercalcemia, hypokalemia, and tumor lysis syndrome, which includes hypocalcemia, hyperphosphatemia, hyperuricemia, and hyperkalemia. These imbalances will each be reviewed with a focus on their causes, signs and symptoms, and treatment. Additional readings on fluid and electrolyte imbalances in patients with cancer can be found in several recent articles.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6757872

Source DB:  PubMed          Journal:  Nurs Clin North Am        ISSN: 0029-6465            Impact factor:   1.208


  4 in total

1.  Urinary parameters predictive and electrolyte disturbances of cisplatin-induced acute renal associated with cancer as a critical target of the chemotherapeutic agent in patients with solid tumors.

Authors:  Behnam Pedram; Ahmad Taghavi Moghadam; Zahra Kamyabi-Moghaddam; Omid Mavedati; Babak Abbas Beigi; Adel Khodaei Sharabiyani; Ali Bashiri Dezfuli; Soheil Khalili; Ali Mohammad Bahrami; Alireza Nasoori
Journal:  Tumour Biol       Date:  2015-01-17

2.  Assessment of ondansetron-associated hypokalemia in pediatric oncology patients.

Authors:  Elsa Fiedrich; Vikram Sabhaney; Justin Lui; Maury Pinsk
Journal:  ISRN Oncol       Date:  2012-09-19

Review 3.  Sexual Dimorphism in Colon Cancer.

Authors:  Maria Abancens; Viviana Bustos; Harry Harvey; Jean McBryan; Brian J Harvey
Journal:  Front Oncol       Date:  2020-12-09       Impact factor: 6.244

Review 4.  Tumor lysis syndrome in childhood malignancies.

Authors:  Wing Lum Cheung; Kam Lun Hon; Cheuk Man Fung; Alexander Kc Leung
Journal:  Drugs Context       Date:  2020-02-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.